Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi

Scientific Program · CIOC 2025

CIOC 2025 — Scientific Program

Day-by-day session and presentation schedule

The full CIOC 2025 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Keynote · In-Person

    Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas

    Farid Moinfar · Ordensklinikum Linz Barmherzige Schwestern, Austria

    Introduction : Basal-like breast carcinomas are immunohistochemically positive for basal-type keratins such as K 5/6, K14, and K17 and mostly are triple-negative (negativity for ER, PR, and Her2/neu). “Basal-like” or…

  2. Keynote · In-Person

    Altered expression of endoplasmic reticulum stress response genes and circular RNAs in oral squamous cell carcinoma tumorigenesis

    Vandana Tiwari · Dr. Ram Manohar Lohia Institute of Medical Sciences, India

    Background: Oral squamous cell carcinoma (OSCC) is a leading malignancy with high mortality and poor prognosis. Dysregulation of endoplasmic reticulum stress response (ERSR) genes and circular RNAs (circRNAs)…

  3. Oral · In-Person

    Geospatial variation and assessment of factors with incidence of colorectal cancer at small area

    Getachew Dagne · University of South Florida, United States

    Background : Examining spatial distribution of colorectal cancer (CRC) incidence or mortality is helpful for developing cancer control and prevention programs, or for generating hypotheses. Such an investigation…

  4. Oral · In-Person

    Flow cytometry for diagnosing malignant carcinomatous effusions

    Namrata P Awasthi · Dr. Ram Manohar Lohia Institute of Medical Sciences, India

    Background: The lecture will introduce the audience to commonly utilized techniques for Cytology of malignant fluids including cytospin, cell block and immunohistochemistry. The advantages and limitations of the…

  5. Oral · In-Person

    Effectiveness of homoeopathic medicine for brochogenic carcinoma: A case report with pre & post HRCT report

    Amir Ashraf · Dr. Amir’s Family Homoeopathy Clinic, India

    Homoeopathy is an alternative system of medicine discovered by German physician Samuel Hahnemann in 1796. It has been used by several people for various health conditions globally for more than last 200 years. In India…

  6. Oral · In-Person

    Genome-wide polymorphisms linked to treatment dosing and outcomes in Qatari pediatric acute lymphoblastic leukemia

    Zainab Awada · Sidra Medicine, Qatar

    Background : Childhood acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, yet significant inter-individual variability exists in response to its therapy. Genetic polymorphisms as biomarkers for…

  7. Oral · In-Person

    The potential of Piper longum extract on breast cancer cell proliferation by inducing apoptosis

    Shivam Singh · All India Institute of Medical Sciences, India

    Background : The incidence of breast cancer has increased while the mortality rate has continued to remain high. Effective treatment of this disease is the key to survival. Therefore, this study is a necessity in…

  8. Oral · In-Person

    Horizontal comparison of the trend of pancreatic cancer in China and abroad: Lower development correlates with reduced pancreatic cancer burden, defying SDI-based predictions

    Yuxin Zhu · Nanchang University, China

    Pancreatic cancer (PC), characterized by aggressive progression and poor prognosis, poses a critical global health challenge. This multinational study investigates epidemiological disparities in PC incidence and disease…

  9. Oral · In-Person

    Unveiling gaps in cancer care: A qualitative study on the needs of patients from Northeast India

    Redolen Rose Dhar · Manipal Academy of Higher Education, India

    Background : Cancer is the leading cause of death worldwide, with the WHO projecting a 45% increase in global cancer deaths from 2008 to 2030 (1, 2). Beyond health impacts, cancer imposes significant economic strains…

  10. Oral · In-Person

    Survivin and its splicing isoforms gene expression in oral squamous cell carcinoma patients

    Phyu Ou Maung · University of Dental Medicine, Myanmar

    Background: Oral squamous cell carcinoma (OSCC) has become a major oncologic problem. Survivin overexpression in OSCC could be associated with increased aggressiveness, poor response to chemotherapy and prediction of…

  11. Oral · In-Person

    Decoding the universal proliferative engine of pituitary adenomas: From single-cell insights to cross-subtype therapeutic innovation

    Changqin Pu · Peking Union Medical College Hospital, China

    Objective: Pituitary adenomas (PAs) are clinically heterogeneous tumors with subtype-specific hormonal profiles, yet current therapies remain largely reactive and fail to address their proliferative core. This study…

  12. Oral · In-Person

    Temozolomide treatment in refractory pituitary adenomas and pituitary carcinomas

    Congcong Deng · Peking Union Medical College Hospital, China

    Refractory pituitary adenomas (RPAs) and pituitary carcinomas (PCs) present significant therapeutic challenges, as they often do not respond to conventional treatment modalities such as surgery, radiation, and…

  13. Oral · In-Person

    Cancer-associated fibroblasts derived soluble CADM1 predicts response to neoadjuvant chemoimmunotherapy in lung cancer

    Jian Li · Shanghai Jiaotong University, China

    Conventional neoadjuvant chemotherapy offers limited benefit for patients with resectable non-small-cell lung cancer (NSCLC). Recently, neoadjuvant chemoimmunotherapy (NCIT) has transformed perioperative management of…

  14. Oral · In-Person

    Importin7 induces M2 macrophage and promotes the progress of colorectal cancer by regulating the nucleus translocation of GRP78

    Changjiang Yang · Peking University People's Hospital, China

    Recent research has linked Importin7 to cancer aggressiveness and a dismal prognosis, but its function in colorectal cancer (CRC) is unclear. This study aimed to elucidate the clinical relevance, biological function…

  15. Oral · In-Person

    Community health workers role in advancing cervical cancer prevention and HPV vaccination in Mukono district, Uganda

    Pauline Picho Keronyai · Nama Wellness Community Centre (NAWEC), Uganda

    Cervical cancer remains a significant public health challenge in Africa, with the continent bearing approximately 19% of global cases. The East African region reports particularly concerning statistics, with an…

  16. Oral · In-Person

    The prevention of post-ESD stricture of large early esophageal cancer by periodic triamcinolone injection

    Li Mian Er · The Fourth Hospital of Hebei Medical University, China

    Objective :Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer,but the post-ESD stricture rate of patients with a post-ESD mucosal defect of ≥ 3/4 of the esophageal circumference is…

  17. Poster · In-Person

    BATF upregulates RGS2 expression to promote T cell exhaustion in lung cancer by activating the NF-kB pathway

    Chanchan Gao · Zhongda Hospital, Southeast University, China

    Objective: This study aimed to investigate the role of RGS2 in immune regulation and its impact on the efficacy of PD-1/PD-L1 blockade therapy in lung cancer (LC), as well as to explore the regulatory relationship…

  18. Poster · In-Person

    Advancing cancer care: The impact of MYCNOS-SE on chemoresistance in SCLC

    Yuchun Niu · Oncology Hospital of the First People's Hospital of Foshan, China

    Understanding the Role of Super-enhancer MYCNOS-SE in Chemoresistance of Small Cell Lung Cancer. Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid progression and a high propensity…

  19. Poster · In-Person

    ADGRE+ CD8+ T cells overcome resistance to neoadjuvant immunotherapy in lung cancer

    Jian Li · Shanghai Jiaotong University, China

    Neoadjuvant immunotherapy with anti-programmed death-1 (neo-antiPD1) has revolutionized perioperative treatment for improving the overall survival (OS) of patients with early-stage lung cancer. Despite its…

Day 2

Day 2

  1. Keynote · Virtual

    Principles of oral rehabilitation in H&N cancer patients

    Pietro Salvatori · Formerly, Humanitas San Pio X Hospital, Italy

    Treatment goals for Head & Neck cancers can be indicated as: 1) Eradication of the tumor (ablative surgery or XRT, combinations), 2) Restoration of the anatomy (reconstructive surgery), 3) Rehabilitation of the…

  2. Keynote · Virtual

    The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment

    Bene Ekine-Afolabi · University of East London, United Kingdom

    Drug metabolism is crucial in any functioning of a drug, particularly in drugs for cancer treatment. Several drugs do not function in human body in their original state unless metabolised to its required functioning…

  3. Keynote · Virtual

    Successful tumor growth control using PLGA nanoparticles loaded with selol and nanomaghemite

    Paulo Cesar De Morais · Catholic University of Brasilia, Brazil

    Poly(lactic-co-glycolic acid) (PLGA) nanoparticle has proven extremely useful for drug delivery, thanks to its high biocompatibility, biodegradability, and toxicologically safe degradation products. This talk will…

  4. Keynote · Virtual

    Biosensor-based detection of cancer biomarkers

    Michael Thompson · University of Toronto, Canada

    Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. This approach offers the possibility for biomarker assay…

  5. Keynote · Virtual

    A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy

    Rajvir Dahiya · University of California San Francisco, United States

    Background : Current screening methods, have limitations in the diagnosis and prognosis of prostate cancer. This study examined whether mRNA-genomic biomarkers can improve screening and monitoring of prostate cancer.…

  6. Oral · Virtual

    Protein structure maintenance, intracellular signaling and tumor suppression contributed by zinc finger protein ZMYND10

    Xiangning Zhang · Guangdong Medical University, China

    On short arm of human chromosome 3, a region 3p21, which is deleted in a variety of tumors, harbors a cluster of putative tumor suppressor genes (TSGs). One of the TSG candidates, BLU, coding for a zinc protein ZMYND10…

  7. Oral · Virtual

    Histone lactylation drives oncogenesis and function as a prognostic marker in pancreatic ductal adenocarcinoma

    Wenzhe Si · Peking University Third Hospital, China

    Background: Metabolic reprogramming and epigenetic alterations contribute to the aggressiveness of pancreatic ductal adenocarcinoma (PDAC). Lactate-dependent histone modification is a new type of histone mark, which…

  8. Oral · Virtual

    Autophagy as an immunomodulatory signalosome in toll-like receptors/Wnt-Frizzled mediated inflammatory “gastrohepatic disease-web” in hepatocellular/colorectal/cholangio-carcinomas: Translational research and public health impact in American cohorts of Texas, Nebraska and New York states in USA

    Saumya Pandey · Indira IVF Hospital, India

    Objective : Dissecting the cellular/molecular/genetic regulatory biochemical signaling networks: Autophagy/Toll-like Receptors/Wnt-Frizzled in inflammatory “gastrohepatic disease-web” primarily…

  9. Oral · Virtual

    Bioscope: A new instrumental approach for early diagnosis of oncological diseases

    Luiza Simonyan · L. Orbeli Institute of Physiology of the National Academy of Sciences of Armenia, Armenia

    Modern medical methods of treatment allow in some cases to prevent the development of pathological processes in the human body. It is known that the effectiveness of such therapeutic effects is largely determined by the…

  10. Oral · Virtual

    Association between respiratory tract viral PCR panel results and clinical outcomes in children with cancer and febrile neutropenia

    Özlem Terzi · Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Turkey

    Febrile neutropenia (FEN) is the most common life-threatening complication of childhood cancer. Early initiation of broad-spectrum intravenous antibiotics to patients has reduced the mortality of FEN below 5%. Studies…

  11. Oral · Virtual

    Colorectal cancer and associated risk factors: Case control hospital based study in Egypt

    Ibrahim El Bayoumy · Consultant of Public Health-Ministry of Health, Kuwait

    Background Colorectal cancer accounts for approximately 10% of all annually diagnosed cancers and cancer-related deaths worldwide.1 It is the second most common cancer diagnosed in women and third most in men. In women…

  12. Oral · Virtual

    Breaking the silence: Breast cancer extracellular vesicles as key players in breast cancer immune suppression

    Nayara Delgado André Bortoleto · Federal University of Sao Joao del Rei, Brazil

    Breast cancer is the most prevalent malignancy in women worldwide and remains a leading cause of cancer-related mortality. Immune system controls tumor progression but is often suppressed in breast cancer. Dendritic…

  13. Oral · Virtual

    Developing a digital decision-support tool for personalized treatment of metastatic thyroid cancer

    Marie Fusella Giuntini · University of Corsica, France

    Each year, a high number of new cases of thyroid cancer are identified. Although this disease has a good prognosis, it is often immediately metastatic, which requires removal of the thyroid body, followed by iratherapy…

  14. Oral · Virtual

    A new tension-sensitive signaling pathway involving polymerization of actin prevents chromatin bridge breakage in cytokinesis

    Eleni Petsalaki · University of Crete, Greece

    Chromatin bridges are strands of incompletely segregated DNA connecting the anaphase poles or daughter nuclei. Chromatin bridges can arise from incompletely replicated DNA, defective resolution of DNA catenates or…

  15. Oral · Virtual

    Associated factors to practice of breast cancer screening among women in Parakou at 2021

    Maurice T. Agonnoude · Parakou University, Benin

    Introduction: The integration of breast cancer screening into daily clinical care leads to an early diagnosis and reduces its mortality. However, many women are reluctant and do not get tested. Objective To study the…

  16. Oral · Virtual

    Bioinformatics and genomic approaches for assessing gene fusion process in MCF7 breast cancer cell models under early estradiol stimulation for assessing estrogen receptor β (Erβ) tumor suppressor activity

    Dago Dougba Noel · PELEFORO GON COULIBALY University, Côte d'Ivoire

    Cancers are genetic and epigenetic diseases in which cells divide and grow in uncontrolled ways due to mutations or molecular alterations. Gene fusion phenomena is recurrent in cancer cells. One of the most common…

  17. Poster · Virtual

    Laparoscopic-endoscopic cooperative non-exposed wall-inversion surgery combined with sentinel node navigation surgery in the treatment of early gastric cancer: A multicenter retrospective study

    Shuaiqi Wang · Chongqing University Cancer Hospital, China

    Background : We developed the laparoscopic and endoscopic cooperative surgery (LECS) technique, which combines non-exposed wall-inversion surgery (NEWS) and sentinel node navigation surgery (SNNS) to treat early gastric…

  18. Poster · Virtual

    Laparoscopic-endoscopic cooperative non-exposed wall-inversion surgery combined with sentinel node navigation surgery in treatment of early gastric cancer: A multicenter retrospective study

    Hao Sun · Chongqing University Cancer Hospital, China

    Background : We developed the laparoscopic and endoscopic cooperative surgery (LECS) technique, which combines non-exposed wall-inversion surgery (NEWS) and sentinel node navigation surgery (SNNS) to treat early gastric…

  19. Poster · Virtual

    Development of risk stratification tool to appropriately triage the patients at risk of recurrence in HR+ HER2- early breast cancer

    Somashekhar SP · Aster CMI Hospital, India

    Introduction: HR+/HER2-negative Early Breast Cancer (EBC) is treated with curative intent, but managing locoregional and distant recurrences remains a significant challenge. The lack of a standard risk-identification…

Day 3

Day 3

  1. Keynote · Virtual

    The role of artificial intelligence (AI) in oncology

    Marika Crohns · Impactful Innovations Management Consultants LLC, United Arab Emirates

    Artificial Intelligence (AI) has emerged as a transformative force in oncology, offering unparalleled potential to revolutionize cancer care. By leveraging advanced algorithms and machine learning models, AI enhances…

  2. Keynote · Virtual

    Targeting noncanonical epitopes in anti-cancer immunotherapy

    Michele Mishto · Francis Crick Institute, United Kingdom

    MHC class I complexes can present antigenic peptides that have a sequence produced by post-translational mechanisms such as peptide splicing. Some examples of tumour-associated spliced epitopes have been investigated…

  3. Keynote · Virtual

    Updates on cancer research for detection and management

    Patricia Tai · University of Saskatchewan, Canada

    About 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime and 1 in 4 die of it. I would discuss interesting updates of advances in cancer research. Biomarker assays have become routine for some…

  4. Keynote · Virtual

    RNA binding proteins in the pathogenesis of pediatric cancer

    Atif A Ahmed · Seattle Children’s Hospital, United States

    RNA binding proteins (RBPs) are regulators of RNA metabolism and influence protein expression in various physiologic and pathologic conditions through regulation of RNA splicing, stability and translation. Several…

  5. Keynote · Virtual

    Theory and perspective: How big data and AI accelerate the discovery of a universal cancer principle from the noncoding RNA regime

    Anyou Wang · DIFIBER LLC, United States

    Numerous cancer-related mechanisms are reported daily, yet a universal theory for eradicating all cancers remains elusive. Fortunately, recent advances in big data and AI have identified noncoding RNAs as central…

  6. Oral · Virtual

    Application of magnetic resonance-diffusion weighted imaging in thyroid nodules

    Liling Jiang · Shapingba District People's Hospital of Chongqing, China

    All studies were performed on a 3 T whole-body MRI system (MAGNETOM Prisma, Siemens Healthineers, Erlangen, Germany) using a 16-channel surface coil (Zhongzhi Medical, Jiangsu). Firstly, we evaluated the thyroid nodule…

  7. Oral · Virtual

    Overcoming drug resistance to BET inhibitors by rational combinative strategies

    Jiawei Guo · Sichuan University, China

    Bromodomain and extra-terminal (BET) family members, including BRD2, BRD3, BRD4 and BRDT, function as critical readers of acetylated histones and globally activate oncogene expression. These proteins have emerged as…

  8. Oral · Virtual

    Evaluation of mutational values in cancerous point mutation and innovation of values-effective drugs for cancer treatment

    Ratan Kumar Sarkar · Independent Researcher, India

    The molecular weights of amino acids are time values where integer and decimal part have separate identity but interrelated. Derived from the factor 14.0267 e.g. 119.1197(Thr) – 105.0930(Ser) = 14.0267 = 131.1736(Leu)…

  9. Oral · Virtual

    Efficient anticancer properties of ashwagandha extracted phytochemicals for lower protein expression on U-251 and clove extracts on LN-229 GBM cell lines

    Prabha Muddobalaiah · Ramaiah Institute of Technology, India

    Glioblastoma Multiforme G IV primary malignant Brain tumor medications such as Radiation, Surgery, Gene therapy, Chemotherapy and Ayurveda which are not very much successful with clinical studies. However, the trials…

  10. Oral · Virtual

    Behavior of advanced (T3 & T4) squamous cell carcinoma of the oral cavity

    Gaurav Vishal · Prathima Cancer Institute, India

    Squamous cell carcinoma (SCC) is the most common malignant neoplasm of the oral cavity. SCC is a major health problem for the world. Based on GLOBOCAN estimates, about 377,713 new cancer patients and 177,757 deaths…

  11. Oral · Virtual

    The next generation cancer treatments - the role of genomics and AI

    K R Muralidhar · Karkinos Healthcare Private Limited, India

    The discussion will be on optimum utilization of AI and genomics in delivering personalized treatments inRadiationOncology for better treatment outcome. Artificial Intellignce , Machine learing and Deep learning will…

  12. Oral · Virtual

    Oxidative stress–fighting miRNAs: Targeting cancer’s achilles’ heel

    Sinem Durmus · Izmir Katip Celebi University, Turkey

    Oxidative stress is one of major factors of cancer initiation and progression by inducing damage to cellular macromolecules through the accumulation of reactive oxygen species (ROS). This process contributes to tumor…

  13. Oral

    Development and validation of an inflammatory prognostic index to predict outcomes in advanced/metastatic urothelial cancer patients receiving immune checkpoint inhibitors

    Sara Mokbel · University College London, United Kingdom

    Background : Immune checkpoint inhibitors (ICIs) improve overall survival (OS) in advanced/metastatic urothelial cancer (a/mUC) patients. Preliminary evidence suggests a prognostic role of inflammatory biomarkers in…

  14. Oral · Virtual

    System error in cancer research

    Oleg Bukhtoyarov · Medical Center 39 LLC, Russian Federation

    Undoubtedly, cancer refers to the group called “diseases of civilization”. Over the last 100 years, cancer has become a real nightmare for humanity. Despite having the tremendous world scientific and financial…

  15. Oral · Virtual

    Synthesis and characterization of ruthenium(III) complex containing 2-aminomethyl benzimidazole, and its anticancer activity in in vitro and in vivo models

    Abdel Ghany F. Shoair · Damietta University, Egypt

    A novel ruthenium(III) complex with 2-aminomethyl benzimidazole (AMBI) has been synthesized and characterized by elemental analysis, spectroscopic (FTIR, UV–Vis and XRD), thermal, magnetic and electrochemical…

  16. Oral · Virtual

    Effect of BRCA silence on the nervous system in a murine model of breast cancer

    Andrea González Báez · Autonomous University of Nuevo Leon, Mexico

    Cancer is a complex pathology of great relevance for public health due to its high mortality and morbidity. Specifically breast cancer, is one of the main causes of death in women worldwide, demonstrating that its…

  17. Oral · Virtual

    Superficial radiation ulcer of the skin: Comparison of the innovative photodynamic therapy (used in the first documented Canadian case) with other alternatives

    Patricia Tai · University of Saskatchewan, Canada

    Introduction : Photodynamic therapy (PDT) promotes wound healing while its clinical use is not investigated in human for radiation-induced skin ulcers. Methods and Materials : We documented the first Canadian in-human…

  18. Oral · Virtual

    Proposal for new diagnostic criteria for sarcopenia based on CT imaging in the Saudi population: A novel method in oncology research

    Zahra Husain · Government Hospital, Bahrain

    Background: Sarcopenia has been shown to be an independent predictor of lower overall survival in oncology patients. Several studies have used computed tomography (CT) to measure psoas muscle surface area to define…

  19. Oral · Virtual

    MicroRNA expression analyses reveal biomarker candidates for improved diagnosis and prognosis of pediatric Burkitt lymphoma

    Can Küçük · Dokuz Eylul University, Turkey

    Burkitt lymphoma is the most common non-Hodgkin lymphoma in children. Pediatric Burkitt lymphomas (pBLs) are characterized by fast tumor growth; therefore, rapid diagnosis and initiation of therapy is of utmost…

Present your research at CIOC 2027

Abstract submissions for the 2027 program are open · March 15–17, 2027 · Village Hotel Changi, Singapore.

Submit Abstract →

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us